Case BioScience
Case BioScience is a cGMP-certified manufacturer of chemically defined, animal component-free cryopreservation and embryo culture media, supplying clinical-grade and research-use products to cell and gene therapy developers and assisted reproductive technology clinics across North America, the Middle East, Asia Pacific, Latin America, and Europe.
- Company typePrivate
- Founded2021
- HeadquartersOntario, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Case BioScience does
Case BioScience is a privately held biotechnology manufacturer specializing in chemically defined, animal component-free cryopreservation media and embryo culture solutions, operating under a dual legal entity structure (CaseBioscience Inc. in Ontario, Canada and CaseBioscience LLC in Florida, USA). The company's product portfolio is organized into two lines: a Cell and Gene Therapy (CGT) line including CaseCryo CTG DMSO, CaseCryo NON-DMSO, CaseCryo DMSO 10%, CaseStor HSS hypothermic storage, and CaseBase dissociation and washing media; and an Assisted Reproductive Technology (ART) line of FDA 510(k)-cleared CaseBio Culture and CaseBio Handling media (with and without HSA), plus CaseBio KSOMaa for mammalian embryo research. Manufacturing is conducted under cGMP-aligned, ISO 13485:2016-certified, MDSAP-certified quality systems, with Drug Master Files filed for the clinical-grade CGT products and FDA 510(k) clearance plus Health Canada Class II registration for the ART portfolio.
The company's go-to-market combines direct B2B e-commerce sales in the US and Canada with five exclusive regional channel partners covering the Middle East, Taiwan, Mexico, Ireland, and Turkey. Revenue is generated through one-time unit-priced product sales for catalog media, supplemented by quote-based custom media manufacturing services (formulation development, optimization, and rapid prototyping for small-batch prototypes). Customer segments are horizontally diversified across CGT developers, human ART/IVF clinics, academic and preclinical stem cell researchers, and mammalian reproductive scientists, with scientific conference participation (ASRM, ATW, IETS, ISSCR, ISCT) serving as a key customer acquisition and thought-leadership channel. Pricing is not publicly disclosed; customers request quotes and samples through the website.
Founded with a mission to apply human ART quality and regulatory expertise to the CGT market, Case BioScience has prioritized regulatory depth as its primary moat, with stacked FDA, Health Canada, ISO 13485, MDSAP, and pending MDR certifications enabling both research and clinical supply across multiple jurisdictions. The company is led by President Monica Mezezi and CSO Kevin Flynn, PhD, with a stated team track record of manufacturing Class II and III medical devices under FDA, EMA, MHRA, and ISO 6485 guidelines. As of the latest data, the company has no disclosed funding rounds, M&A activity, or parent company, indicating founder/management ownership with commercial scaling funded internally.
Case BioScience firmographics
Firmographics- Name
- Case BioScience
- Legal name
- CaseBioscience Inc. & CaseBioscience LLC
- Website
- https://casebioscience.com
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Case BioScience is a cGMP-certified manufacturer of chemically defined, animal component-free cryopreservation and embryo culture media, supplying clinical-grade and research-use products to cell and gene therapy developers and assisted reproductive technology clinics across North America, the Middle East, Asia Pacific, Latin America, and Europe.
- Ownership category
- akta.pro rank
Case BioScience industry classification
Industry- Product category
- Cryopreservation Media
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies (HLAAAJAN)
- akta.pro secondary industries
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Biologics (mAbs/Recombinant Proteins) CDMO (HLAGABAC), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)
Keywords
Where Case BioScience is headquartered
LocationHeadquarters
- HQ city
- Ontario
- HQ country
- Canada
- HQ region
- North America
Offices2 records
Markets served
Case BioScience business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure
Revenue model
- Biopreservation Media Products: Sale of cryopreservation solutions including CaseCryo CTG DMSO, CaseCryo NON-DMSO, CaseCryo DMSO 10%, CaseBase Washing Medium, and CaseBase Dissociation Medium for cell therapy workflows. One-time product purchases with repeat orders as part of ongoing research and clinical programs.
- ART Culture Media Products: Sale of FDA-cleared embryo culture and handling media including CaseBio Culture, CaseBio Culture w/HSA, CaseBio Handling, and CaseBio Handling w/HSA for assisted reproductive technology procedures. Health Canada registered products available in USA, Canada, and select countries.
- Custom Media Manufacturing Services: cGMP custom media manufacturing services for tailored solutions to meet specific research and application needs. Services include media development and optimization, and rapid prototyping for small-batch production of media prototypes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Standard Catalog Products - Cryopreservation Media |
| Unit Pricing | Pay-as-you-go | Standard Catalog Products - ART Media |
| Other | Multi-year contract | Custom Manufacturing Services |
Go-to-market motion2 records
Distribution channels6 records
Marketing channels6 records
Case BioScience product offering
Product offeringCore offering
Case BioScience manufactures and sells chemically defined, animal component-free cryopreservation media and embryo culture solutions under ISO 13485:2016-certified cGMP quality systems. The portfolio serves two end-markets: Cell and Gene Therapy (CaseCryo and CaseBase product lines for stem cell preservation and handling) and Assisted Reproductive Technology (FDA-cleared CaseBio Culture and Handling media for IVF clinics). The company also offers custom media manufacturing, formulation development, and rapid prototyping services.
Product overview
CaseBioScience offers a dual-focused portfolio of biopreservation and embryo culture solutions. The Cell and Gene Therapy (CGT) line includes CaseCryo CTG DMSO (clinical-grade cryopreservation), CaseStor HSS (hypothermic storage), CaseCryo NON-DMSO (DMSO-free alternative), CaseCryo DMSO 10%, and CaseBase Dissociation/Washing Media - all designed for stem cell therapy workflows. The Assisted Reproductive Technology (ART) line includes FDA-cleared CaseBio Culture and CaseBio Handling Media (available with or without HSA), plus CaseBio KSOMaa for mammalian embryo research. Products are manufactured under ISO 13485:2016 cGMP standards with applications in cell therapy, regenerative medicine, biobanking, and reproductive medicine.
Differentiator
Problem solved
Functional benefit
Brands
- CaseCryo: Cryopreservation media products including CaseCryo CTG DMSO, CaseCryo NON-DMSO, and CaseCryo DMSO 10% for cell therapy and stem cell applications.
- CaseStor
- CaseBase
- CaseBio
Products and services
- CaseCryo CTG DMSO Clinical-grade DMSO-based cryopreservation solution designed for cell therapy manufacturing and clinical programs, supporting functional performance and lot-to-lot consistency within controlled quality systems for hPSCs, T cells, and MSCs.
- CaseStor HSS Hypothermic Storage Solution Hypothermic storage solution for cells and tissues designed for clinical use, supporting a wide range of applications in cell therapy workflows.
- CaseCryo NON-DMSO
Quantifiable outcome
- Improved post-storage expansion and recovery of hPSCs, T cells, and MSCs compared with leading commercially available solutions
- +2 more outcomes
Companies that use Case BioScience
Customer profileSegments4 records
Ideal customer profiles4 records
Case BioScience technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature4 records
Case BioScience partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Masoud Establishment for Medical and Science SuppliescoreExclusive regional distributor covering Jordan, Bahrain, Cyprus, Egypt, Iran, Iraq, Kuwait, Lebanon, Oman, Palestine, Qatar, Saudi Arabia, Syrian Arab Republic, United Arab Emirates, and Yemen. Located at Noah Center, Al-Jubaiha, Amman, Jordan. Provides local sales, distribution, and customer support for CaseBioscience products in the Middle East region.
- Mitek Lab Co., LTD.coreRegional distributor for Taiwan covering local sales and distribution of CaseBioscience products. Located at 11F No. 139, Fuhe Rd., Yonghe Dist, New Taipei City, Taiwan R.O.C.
- Nanog BioteccoreRegional distributor for Mexico covering local sales and distribution of CaseBioscience products. Located at Calle Alejandro #3152, Colonia Vallarta San Jorge, Guadalajara, Jalisco, México.
- Mitrone Healthcare Ltd.coreRegional distributor for Ireland covering local sales and distribution of CaseBioscience products. Located at 9 Ardagh Avenue, Blackrock, County Dublin, Ireland, A94 HP68.
- Ren A LifecoreRegional distributor for Turkey covering local sales and distribution of CaseBioscience products. Contact person Tarhan Bora.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Case BioScience competitors and assessment
Company assessmentDirect peers
- BioLife Solutions: BioLife Solutions is the most direct competitor in biopreservation media for cell and gene therapy, offering CryoStor and HypoThermosol — direct analogues to CaseCryo CTG DMSO and CaseStor HSS. Like Case BioScience, it supplies cGMP-grade cryopreservation solutions into CGT manufacturing workflows.
- FUJIFILM Irvine Scientific: FUJIFILM Irvine Scientific is a leading manufacturer of ART/IVF media (similar to CaseBio Culture/Handling) and also serves cell therapy developers with adjacent media and reagents. It is one of the most direct competitors in Case BioScience's dual ART/CGT positioning.
- Vitrolife: Vitrolife is a global leader in ART media and IVF lab disposables, competing head-on with CaseBio Culture and CaseBio Handling in clinical IVF. It serves the same ART clinic customer base with a broader, more established product portfolio.
Broad incumbents
- CooperSurgical: CooperSurgical (part of CooperCompanies) is a large incumbent in ART/fertility products, including embryo culture and handling media. It competes with the CaseBio portfolio across the same IVF clinic channel with much broader scale.
- Lonza: Lonza is a major CDMO and cell therapy media supplier offering cryopreservation solutions and cell processing products (e.g., Cocoon, CryoMACS). It competes in the same CGT manufacturing customer base as Case BioScience with significantly greater scale and breadth.
- Thermo Fisher Scientific (Gibco / CTS): Thermo Fisher's Gibco and Cell Therapy Systems (CTS) brands supply cryopreservation media (e.g., Synth-a-Freeze, CTS Cryopreservation) and culture media for CGT developers. It is a broad incumbent across nearly all the segments Case BioScience addresses.
- Merck KGaA (MilliporeSigma / BioReliance): MilliporeSigma supplies cryopreservation media, cell culture reagents, and bioprocessing services into CGT manufacturing — directly overlapping with CaseCryo, CaseBase, and the custom media services offering. It is a broad incumbent with deep pharma and CGT relationships.
- Bio-Techne: Bio-Techne (R&D Systems, Tocris, ProteinSimple) supplies reagents and media used in cell and gene therapy research workflows. While broader than Case BioScience, it competes for the same research-use-only wallet of academic and preclinical cell therapy customers.
Emerging players
- STEMCELL Technologies: STEMCELL Technologies is a private developer of cell culture media, cryopreservation reagents, and stem cell research tools. It overlaps with Case BioScience's research-use-only product line and the stem cell workflow customer base, though it is less focused on clinical-grade ART.
Others
- Cryoport Systems: Cryoport is a specialty logistics provider for temperature-controlled life sciences shipments, including cryopreserved cell therapies. It is an adjacent/ecosystem participant rather than a direct media competitor, but operates in the same cell therapy cold-chain value chain.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Case BioScience social profiles
Digital presenceCase BioScience compliance and trust
Trust signalCompliance4 records
Case BioScience financial estimates
Financial estimateRevenue estimate
Valuation estimate
Case BioScience leadership team
Management profileNumber of profiles
Profiles2 records
Case BioScience funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Case BioScience M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Case BioScience
What does Case BioScience do?
Case BioScience manufactures and sells chemically defined, animal component-free cryopreservation media and embryo culture solutions under ISO 13485:2016-certified cGMP quality systems. The portfolio serves two end-markets: Cell and Gene Therapy (CaseCryo and CaseBase product lines for stem cell preservation and handling) and Assisted Reproductive Technology (FDA-cleared CaseBio Culture and Handling media for IVF clinics). The company also offers custom media manufacturing, formulation development, and rapid prototyping services.
Is Case BioScience a public or private company?
Case BioScience is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Case BioScience founded?
Case BioScience was founded in 2021. It employs 11 to 50 people.
Where is Case BioScience based?
Case BioScience is headquartered in Ontario, Canada, in the North America region.
How does Case BioScience make money?
Three revenue lines are on record. Biopreservation Media Products are the primary driver. The others are ART Culture Media Products and custom Media Manufacturing Services.
Who are Case BioScience's main competitors?
Direct peers on record are BioLife Solutions, FUJIFILM Irvine Scientific and Vitrolife. Broad incumbents are CooperSurgical, Lonza, Thermo Fisher Scientific (Gibco / CTS), Merck KGaA (MilliporeSigma / BioReliance) and Bio-Techne. STEMCELL Technologies is listed as an emerging player. Cryoport Systems is listed as an others.
Does Case BioScience have an API?
No public API is recorded for Case BioScience.
What industry is Case BioScience in?
Case BioScience's product category is Cryopreservation Media. Its primary akta.pro industry code is HLAAAJAN, Cold Chain, Cryopreservation & Biologics Storage/Handling Technologies, with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 325414 and its SIC code is 2836.